Immunotherapy

Papers
(The H4-Index of Immunotherapy is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Immortal Time Bias in the Association Between Toxicity and Response for Immune Checkpoint Inhibitors: A Meta-Analysis93
Pasotuxizumab, a Bite ® Immune Therapy for Castration-Resistant Prostate Cancer: Phase I, Dose-Escalation Study Findings83
Atezolizumab in Advanced Hepatocellular Carcinoma: Good Things Come to Those Who Wait68
A Global Picture: Therapeutic Perspectives for COVID-1957
Systemic Immune–Inflammation Index Predicts Prognosis of Cancer Immunotherapy: Systemic Review and Meta-Analysis47
Real-world Study of Hepatic Artery Infusion Chemotherapy Combined With Anti-PD-1 Immunotherapy and Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma45
Immune Checkpoint Inhibitors and Chemotherapy in First-Line NSCLC: a Meta-Analysis35
TYK2 as a Therapeutic Target in the Treatment of Autoimmune and Inflammatory Diseases35
Tumor Cell-Based Vaccine: An Effective Strategy for Eradication of Cancer Cells33
Antimicrobial/Anticancer Peptides: Bioactive Molecules and Therapeutic Agents31
Cytokine Storm Modulation in COVID-19: A Proposed Role for Vitamin D and DPP-4 Inhibitor Combination Therapy (VIDPP-4i)31
Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcoma31
Immunotherapy for Gastric Cancer: A 2021 Update27
Therapeutics to Tackle Omicron Outbreak27
Sutimlimab for Treatment of Cold Agglutinin Disease: Why, How And For Whom?27
Production of Hyperimmune Anti-SARS-CoV-2 Intravenous Immunoglobulin from Pooled COVID-19 Convalescent Plasma26
Peripheral Blood Eosinophil Count is Associated with Response to Chemoimmunotherapy in Metastatic Triple-Negative Breast Cancer25
Atherosclerosis: Immunopathogenesis and Strategies for Immunotherapy23
Blocking Egfr with Nimotuzumab: A Novel Strategy for Covid-19 Treatment22
Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer22
Targeted Allergen-Specific Immunotherapy within the Skin Improves Allergen Delivery to Induce Desensitization to Peanut21
0.048572063446045